In the evolving field of biochemical research, specific molecular structures often garner LucaVax (tertomotide) / GemVax & KAEL, Samsung Pharm sign by JA Kyte·2009·Cited by 126—The present review provides an update on the development of GV1001, a peptide vaccine representing a16-aa hTERT sequence.Read more ificant attention due to their unique properties. Among these, the GV1001 peptide sequence stands out as a subject of intense scientific inquiry. Often categorized as a synthetic telomerase-specific peptide vaccine, it represents a precise arrangement of building blocks that researchers utilize to explore various biological interactions.
Molecular Architecture of GV1001
At its core, GV1001 is a 16-amino-acid peptide. This specific chain is derived from the catalytic site of the human telomerase reverse transcriptase (hTERT) protein, specifically spanning residues 611–626. The structural integrity of this molecule is defined by the follow by SL Bernhardt·2006·Cited by 411—The telomerase peptide used in this study,GV1001; hTERT (611–626) is a promiscuous HLA class II epitope, a property making GV1001 a Read more ing 16-aa hTERT sequence:
H-Glu-Ala-Arg-Pro-Ala-Leu-Leu-Thr-Ser-Arg-Leu-Arg-Phe-Ile-Pro-Lys
This precise amino acid arrangement is what distinguishes the molecule in laboratory settings. Because GV1001 is a 16-amino acid peptide sequence of hTERT protein, it has become a standard reference point for those studying the functional properties of telomerase-derived structures.
Scientific Context and Research Applications
When reviewing literature or laboratory datasets, one will often encounter G Tertomotide (also known as GV1001)is a synthetic telomerase-specific peptide vaccinepatented by Norsk Hydro Asa for the cancer treatment.Read more V10 by JH Kim·2025·Cited by 1—Data Article. Transcriptomic and functional annotation datasets forGV1001 peptide treatmentin an experimental autoimmune encephalomyelitis mouse model.Read more 01 in the context of advanced biochemical studies. It is important to note that GV1001 is a 16-amino-acid peptide that has been extensively documented in academic databases like PubMed and PMC. Beyond its primary classification, GV1001 is a vaccine peptide derived from a 16-amino-acid sequence from the active site of the enzyme, which allows researchers to investigate its potential in various experimental models.
For those interested in the technical nomenclature, the substance is also known as tertomotide. Whether referred to as peptide GV1001 or by its synonym, the molecule consistently displays the same 16-aa human telomerase reverse transcriptase (hTERT) sequence.
Key Characteristics:
* S Cancer vaccination with telomerase peptide GV1001 tructure: A linear chain of 16 amino acids.
* Origin: Derived from the hTERT protein (residues 611–626).
* Classification: Often investigated as a synthetic telomerase-specific peptide vaccine.
* Synonyms: Known in various research archives as RIAVAX (also known as GV1001) or tertomotide.
Navigating Research Data
When analyzing GV1001 peptide treatment datasets, researchers often focus on the specific sequences involved in protein-protein interactions. The GV1001; hTERT (611–626) designation is frequently used to ensure accuracy when documenting experimental conditions.
It is noteworthy that GV1001 is a 16-amino acid peptide that exhibits high specificity. In many studies, GV1001, a 16-mer peptide, is utilized to observe how such a small structure can influence biological pathways. Because GV1001 is a 16-amino-acid vaccine peptide, it serves as a foundational tool for those exploring the mechanisms of telomerase inhibition or modulation in non-human, controlled environments.
Conclusion
The study of peptide structures requires a deep understanding of primary sequences and their functional implications. As a peptide consisting of 16 amino acids, GV1001 offers a clear, qu Novel vaccine peptide GV1001 effectively blocks β-amyloid antifiable subject for biochemical analysis. While many recognize it as GV1001, an anticancer vaccine in its historical context, modern research continues to uncover its diverse roles in experimental biology. By focusing on the precise 16-aa hTERT sequence, scientists can continue to refine their approach to utilizing this unique peptide in various laboratory applications.
*Note: This information is provided for educational and research-related purposes only. GV1001 is a chemical compound intended for laboratory use, not for human consumption or medical treatment.*